Onyx Health's Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own ...
AstraZeneca (AZ) has begun the global withdrawal of its COVID-19 vaccine, citing a “surplus” of vaccines that have been ...
A new clinical trial led by the University of Birmingham and the University of Glasgow has revealed that an additional ...
Gilead Sciences has announced the appointment of Peter Wickersham as vice-president and general manager for the UK and Ireland. In his new role, Wickersham will be responsible for leading Gilead’s ...
The UK government has announced the launch of a new five-year national action plan aimed at tackling antimicrobial resistance (AMR), which has been declared by the World Health Organization as one of ...
Sanofi, Pfizer and AstraZeneca (AZ) have committed a total of €2.5bn to biomanufacturing projects in France ahead of the foreign direct investment summit, Choose France, in Versailles. The ...
Takeda and AC Immune have entered into a worldwide option and licence agreement worth over $2.1bn for an investigational Alzheimer’s disease (AD) drug. AD is the most common form of dementia, which ...
LEO Pharma has shared positive results from a late-stage trial of Enstilar (LEO 90100) in adults with stable plaque psoriasis. Between 2% and 3% of the global population has some form of psoriasis, a ...
Tiziana Life Sciences has shared positive three-month neuroimaging scores in non-active secondary progressive multiple sclerosis (na-SPMS) patients receiving intranasal foralumab. Affecting ...
The treatment reduced RSV hospitalisations by 82% in infants under six months during the 2023 to 2024 RSV season AstraZeneca (AZ) and Sanofi have shared new positive real-world data for Beyfortus ...
His Majesty King Charles III has approved the Prime Minister’s recommendation that global healthcare consultancy, Uptake should receive The King’s Award for Enterprise in the International Trade ...
The digital revolution is re-shaping every industry, and those of us working in healthcare have the opportunity to lead this transformation. We are now in a position where prescription and ...